Combination of talazoparib and olaparib enhanced the curcumin-mediated apoptosis in oral cancer cells by PARP-1 trapping
Тип публикации: Journal Article
Дата публикации: 2022-08-13
SCImago Q1
WOS Q2
БС2
SJR: 0.954
CiteScore: 6.4
Impact factor: 3.3
ISSN: 01715216, 14321335
PubMed ID:
35962813
Cancer Research
Oncology
General Medicine
Краткое описание
Inhibition of Poly (ADP-ribose) Polymerases (PARP) results in the blocking of DNA repair cascades that eventually leads to apoptosis and cancer cell death. PARP inhibitors (PARPi) exhibit their actions either by inhibiting PARP-induced PARylation and/or by trapping PARP at the DNA damage site. But, the mechanism of PARPi-mediated induction of cellular toxicity via PARP-trapping is largely unknown. The cellular toxicity of PARPi [Talazoparib (BMN) and/or Olaparib (Ola)] was investigated in oral cancer cells and the underlying mechanism was studied by using in vitro, in silico, and in vivo preclinical model systems. The experimental data suggested that induction of DNA damage is imperative for the optimal effectiveness of PARPi. Curcumin (Cur) exhibited maximum DNA damaging capacity in comparison to Resveratrol and 5-Flurouracil. Combination of BMN + Ola induced cell death in Cur pre-treated cells at much lower concentrations than their individual treatments. BMN + Ola treatment deregulated the BER cascade, potentiated PARP-trapping, caused cell cycle arrest and apoptosis in Cur pre-treated cells in a much more effective manner than their individual treatments. In silico data indicated the involvement of different amino acid residues which might play important roles in enhancing the BMN + Ola-mediated PARP-trapping. Moreover, in vivo mice xenograft data also suggested the BMN + Ola-mediated enhancement of apoptotic potentiality of Cur. Thus, induction of DNA damage was found to be essential for optimal functioning of PARPi and BMN + Ola combination treatment enhanced the apoptotic potentiality of Cur in cancer cells by enhancing the PARP-trapping activity via modulation of BER cascade.
Найдено
Ничего не найдено, попробуйте изменить настройки фильтра.
Для доступа к списку цитирований публикации необходимо авторизоваться.
Топ-30
Журналы
|
1
2
3
|
|
|
Bioorganic Chemistry
3 публикации, 12.5%
|
|
|
Expert Opinion on Therapeutic Targets
2 публикации, 8.33%
|
|
|
Medical Oncology
2 публикации, 8.33%
|
|
|
Experimental Cell Research
1 публикация, 4.17%
|
|
|
Molecules
1 публикация, 4.17%
|
|
|
Journal of Cell Communication and Signaling
1 публикация, 4.17%
|
|
|
Pharmaceutics
1 публикация, 4.17%
|
|
|
Environmental Research
1 публикация, 4.17%
|
|
|
Translational Oncology
1 публикация, 4.17%
|
|
|
Nanomedicine
1 публикация, 4.17%
|
|
|
RSC Medicinal Chemistry
1 публикация, 4.17%
|
|
|
Molecular and Cellular Biochemistry
1 публикация, 4.17%
|
|
|
Frontiers in Pharmacology
1 публикация, 4.17%
|
|
|
Bulletin du Cancer
1 публикация, 4.17%
|
|
|
Journal of Biomaterials Science, Polymer Edition
1 публикация, 4.17%
|
|
|
Russian Chemical Reviews
1 публикация, 4.17%
|
|
|
Drug Design, Development and Therapy
1 публикация, 4.17%
|
|
|
Applied Sciences (Switzerland)
1 публикация, 4.17%
|
|
|
Archives of Pharmacal Research
1 публикация, 4.17%
|
|
|
Journal for ImmunoTherapy of Cancer
1 публикация, 4.17%
|
|
|
1
2
3
|
Издатели
|
1
2
3
4
5
6
7
|
|
|
Elsevier
7 публикаций, 29.17%
|
|
|
Springer Nature
5 публикаций, 20.83%
|
|
|
Taylor & Francis
5 публикаций, 20.83%
|
|
|
MDPI
3 публикации, 12.5%
|
|
|
Royal Society of Chemistry (RSC)
1 публикация, 4.17%
|
|
|
Frontiers Media S.A.
1 публикация, 4.17%
|
|
|
Autonomous Non-profit Organization Editorial Board of the journal Uspekhi Khimii
1 публикация, 4.17%
|
|
|
BMJ
1 публикация, 4.17%
|
|
|
1
2
3
4
5
6
7
|
- Мы не учитываем публикации, у которых нет DOI.
- Статистика публикаций обновляется еженедельно.
Вы ученый?
Создайте профиль, чтобы получать персональные рекомендации коллег, конференций и новых статей.
Войти с ORCID
Метрики
24
Всего цитирований:
24
Цитирований c 2025:
10
(41.66%)
Цитировать
ГОСТ |
RIS |
BibTex |
MLA
Цитировать
ГОСТ
Скопировать
Chatterjee S. et al. Combination of talazoparib and olaparib enhanced the curcumin-mediated apoptosis in oral cancer cells by PARP-1 trapping // Journal of Cancer Research and Clinical Oncology. 2022. Vol. 148. No. 12. pp. 3521-3535.
ГОСТ со всеми авторами (до 50)
Скопировать
Chatterjee S., Dhal A. K., Paul S., Sinha S., Das B., Dash S. R., Kundu C. N. Combination of talazoparib and olaparib enhanced the curcumin-mediated apoptosis in oral cancer cells by PARP-1 trapping // Journal of Cancer Research and Clinical Oncology. 2022. Vol. 148. No. 12. pp. 3521-3535.
Цитировать
RIS
Скопировать
TY - JOUR
DO - 10.1007/s00432-022-04269-7
UR - https://doi.org/10.1007/s00432-022-04269-7
TI - Combination of talazoparib and olaparib enhanced the curcumin-mediated apoptosis in oral cancer cells by PARP-1 trapping
T2 - Journal of Cancer Research and Clinical Oncology
AU - Chatterjee, Subhajit
AU - Dhal, Ajit Kumar
AU - Paul, Subarno
AU - Sinha, Saptarshi
AU - Das, Biswajit
AU - Dash, Somya Ranjan
AU - Kundu, Chanakya Nath
PY - 2022
DA - 2022/08/13
PB - Springer Nature
SP - 3521-3535
IS - 12
VL - 148
PMID - 35962813
SN - 0171-5216
SN - 1432-1335
ER -
Цитировать
BibTex (до 50 авторов)
Скопировать
@article{2022_Chatterjee,
author = {Subhajit Chatterjee and Ajit Kumar Dhal and Subarno Paul and Saptarshi Sinha and Biswajit Das and Somya Ranjan Dash and Chanakya Nath Kundu},
title = {Combination of talazoparib and olaparib enhanced the curcumin-mediated apoptosis in oral cancer cells by PARP-1 trapping},
journal = {Journal of Cancer Research and Clinical Oncology},
year = {2022},
volume = {148},
publisher = {Springer Nature},
month = {aug},
url = {https://doi.org/10.1007/s00432-022-04269-7},
number = {12},
pages = {3521--3535},
doi = {10.1007/s00432-022-04269-7}
}
Цитировать
MLA
Скопировать
Chatterjee, Subhajit, et al. “Combination of talazoparib and olaparib enhanced the curcumin-mediated apoptosis in oral cancer cells by PARP-1 trapping.” Journal of Cancer Research and Clinical Oncology, vol. 148, no. 12, Aug. 2022, pp. 3521-3535. https://doi.org/10.1007/s00432-022-04269-7.
Ошибка в публикации?